【AIGC One Sentence Reading】:We developed an injectable nanorobot-hydrogel superstructure for HCC spinal metastasis, reducing bleeding & tumor growth preoperatively.
【AIGC Short Abstract】:A novel injectable nanorobot-hydrogel superstructure is developed for spinal metastasis treatment. It controls intraoperative bleeding by inducing thrombosis and inhibits tumor growth with photothermal therapy. This minimally invasive platform shows promise in enhancing surgical outcomes for hepatocellular carcinoma spinal metastasis.
Note: This section is automatically generated by AI . The website and platform operators shall not be liable for any commercial or legal consequences arising from your use of AI generated content on this website. Please be aware of this.
Abstract
Surgery remains the standard treatment for spinal metastasis. However, uncontrolled intraoperative bleeding poses a significant challenge for adequate surgical resection and compromises surgical outcomes. In this study, we develop a thrombin (Thr)-loaded nanorobot-hydrogel hybrid superstructure by incorporating nanorobots into regenerated silk fibroin nanofibril hydrogels. This superstructure with superior thixotropic properties is injected percutaneously and dispersed into the spinal metastasis of hepatocellular carcinoma (HCC) with easy bleeding characteristics, before spinal surgery in a mouse model. Under near-infrared irradiation, the self-motile nanorobots penetrate into the deep spinal tumor, releasing Thr in a controlled manner. Thr-induced thrombosis effectively blocks the tumor vasculature and reduces bleeding, inhibiting tumor growth and postoperative recurrence with Au nanorod-mediated photothermal therapy. Our minimally invasive treatment platform provides a novel preoperative therapeutic strategy for HCC spinal metastasis effectively controlling intraoperative bleeding and tumor growth, with potentially reduced surgical complications and enhanced operative outcomes.
The Author Email: Kong Biao (bkong@fudan.edu.cn), Hong Wei (drivyh@126.com), Jiang Libo (jiang.libo@zs-hospital.sh.cn), Dong Jian (dong.jian@zs-hospital.sh.cn)